ArticleJACC. Cardiovascular interventions2023
Contemporary Methods for Predicting Acute Kidney Injury After Coronary Intervention.
Article in JACC. Cardiovascular interventions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 27 citations in OpenAlex.
- Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Trial
- Lower AKI Risk and Higher Survival With Microaxial Flow Pump Support During Elective PCI: A Propensity Score-Matched Study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026Observational
- Prognostic impact of acute kidney injury on one-year survival in patients undergoing high-risk PCI with Impella support.Scientific reports · 2026Article
- An interpretable XGBoost model for contrast-associated acute kidney injury in patients with acute coronary syndrome: development and geographical external validation.Frontiers in digital health · 2026Article
- Mitochondrial DNA methylation is involved in contrast-induced renal tubular epithelial cell injury.Renal failure · 2025Article
- Acute kidney injury among patients aged over 80 years after percutaneous coronary intervention: a multicenter, retrospective cohort study.Renal failure · 2025Article
- Nomogram for predicting acute kidney injury after primary PCI in STEMI patients: development and validation study.Renal failure · 2025Article
- Association of Acute Kidney Injury Risk and Same-Day Discharge Practices After Percutaneous Coronary Intervention.Journal of the American Heart Association · 2025Observational
- Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort study.European journal of heart failure · 2025Article
- Development of a machine learning-based prediction model for acute kidney injury associated with respiratory failure in the intensive care unit.Clinical and experimental medicine · 2025Article
- Left-Digit Bias in Serum Creatinine Levels and Contrast Administration: A Nationwide Cohort Study Using a Japanese Percutaneous Coronary Intervention Registry.Journal of the American Heart Association · 2025Article
- Risk-Stratified Prognostic Implications of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention.JACC. Advances · 2025Article
- Trends and Physician-Level Variation in Contrast Volume During Percutaneous Coronary Intervention: Insights From the NCDR CathPCI Registry.Journal of the American College of Cardiology · 2025Article
- Association between the triglyceride-glucose index and acute kidney injury in patients undergoing percutaneous coronary: a retrospective analysis of the MIMIC-IV database.Diabetology & metabolic syndrome · 2025Article
- Personalized contrast agent dosing to prevent contrast induced nephropathy in high risk populations in Guangdong, China.Scientific reports · 2025Observational
- Development and validation of a risk prediction model for acute kidney injury in coronary artery disease.BMC cardiovascular disorders · 2025Article
- Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States.Journal of the American College of Cardiology · 2024Article
- Lactate dehydrogenase-to-albumin ratio: A superior inflammatory marker for predicting contrast-associated acute kidney injury after percutaneous coronary intervention.Clinical cardiology · 2024Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 8 institutions in 1 country.
Funding
Abstract
backgroundAcute kidney injury (AKI) is the most common complication after percutaneous coronary intervention (PCI). Accurately estimating patients' risks not only creates a means of benchmarking performance but can also be used prospectively to inform practice.
objectivesThe authors sought to update the 2014 National Cardiovascular Data Registry (NCDR) AKI risk model to provide contemporary estimates of AKI risk after PCI to further improve care.
methodsUsing the NCDR CathPCI Registry, we identified all 2020 PCIs, excluding those on dialysis or lacking postprocedural creatinine. The cohort was randomly split into a 70% derivation cohort and a 30% validation cohort, and logistic regression models were built to predict AKI (an absolute increase of 0.3 mg/dL in creatinine or a 50% increase from preprocedure baseline) and AKI requiring dialysis. Bedside risk scores were created to facilitate prospective use in clinical care, along with threshold contrast doses to reduce AKI. We tested model calibration and discrimination in the validation cohort.
resultsAmong 455,806 PCI procedures, the median age was 67 years (IQR: 58.0-75.0 years), 68.8% were men, and 86.8% were White. The incidence of AKI and new dialysis was 7.2% and 0.7%, respectively. Baseline renal function and variables associated with clinical instability were the strongest predictors of AKI. The final AKI model included 13 variables, with a C-statistic of 0.798 and excellent calibration (intercept = -0.03 and slope = 0.97) in the validation cohort.
conclusionsThe updated NCDR AKI risk model further refines AKI prediction after PCI, facilitating enhanced clinical care, benchmarking, and quality improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.